Fidelity Select Biotechnology (FBIOX - Free Report) a Zacks Rank #2 (Buy) seeks capital appreciation. FBIOX normally invests at least 80% of assets in common stocks of companies principally engaged in the research, development, manufacture, and distribution of various biotechnological products, services, and processes and companies that benefit significantly from scientific and technological advances in biotechnology. FBIOX was created in December 1985 and managed by the Fidelity Group.

This fund, as of the last filing, allocates their fund in one major group; Small Growth. Further, as of the last filing, Regeneron Pharmaceuticals, Alexion Pharmaceuticals and Vertex Pharmaceuticals were the top holdings for FBIOX.

Fidelity Select Biotechnology, managed by Fidelity, carries an expense ratio of 0.74%. Moreover, FBIOX requires a minimal initial investment of $2,500.

FBIOX has a history of positive total returns for over 10 years. Specifically, the fund’s returns over the 1, 3, 5 year benchmarks; 3 year 7.93% and 5 year 23.72%. To see how this fund performed compared in its category and other #1 and #2 Ranked Mutual Funds, please click here.

FBIOX’s performance, as of the last filing, when compared to funds in its category was in the top 94% in 1 year, top 48% over the past 3 years, and in the 2% over the past 5 years.